MCQ Quiz- The Human Genome Project

MCQ Quiz: The Human Genome Project

by

The Human Genome Project (HGP) was a monumental international research effort that fundamentally changed our understanding of human biology and paved the way for the era of genomic medicine. For pharmacists, the legacy of the HGP is the foundation upon which personalized medicine, pharmacogenomics, and novel targeted therapies are built. This quiz for PharmD students will test your knowledge of this landmark project, its goals, its findings, and its profound impact on the future of pharmacy.

1. What was the primary, overarching goal of the Human Genome Project (HGP)?

  • To cure all genetic diseases.
  • To clone a human being.
  • To determine the sequence of the nucleotide base pairs that make up human DNA and to identify and map all of the human genes.
  • To create a comprehensive catalog of all proteins in the human body.

Answer: To determine the sequence of the nucleotide base pairs that make up human DNA and to identify and map all of the human genes.

2. The Human Genome Project was officially launched in what year?

  • 1980
  • 1990
  • 2000
  • 2010

Answer: 1990

3. A key principle of the HGP was that all data generated would be:

  • Kept secret and proprietary by the research institutions.
  • Made publicly available to accelerate research and development worldwide.
  • Sold to the highest-bidding pharmaceutical company.
  • Released only after a 10-year waiting period.

Answer: Made publicly available to accelerate research and development worldwide.

4. One of the surprising findings of the HGP was that the number of protein-coding genes in a human is approximately:

  • 100,000 to 150,000
  • 50,000 to 75,000
  • 20,000 to 25,000
  • Over 1 million

Answer: 20,000 to 25,000

5. The HGP revealed that what percentage of the human genome consists of protein-coding sequences (exons)?

  • About 50%
  • About 25%
  • About 10%
  • Less than 2%

Answer: Less than 2%

6. A major branch of the Human Genome Project was dedicated to studying the ethical, legal, and social implications of genomic knowledge. This program is known by what acronym?

  • FDA (Food and Drug Administration)
  • NIH (National Institutes of Health)
  • ELSI (Ethical, Legal, and Social Implications)
  • HIPAA (Health Insurance Portability and Accountability Act)

Answer: ELSI (Ethical, Legal, and Social Implications)

7. The primary DNA sequencing method used for the majority of the Human Genome Project was:

  • Next-generation sequencing (NGS).
  • Sanger sequencing.
  • Nanopore sequencing.
  • Microarray analysis.

Answer: Sanger sequencing.

8. The HGP was a catalyst for the development of which much faster and cheaper sequencing technology?

  • Karyotyping
  • Southern blotting
  • Next-generation sequencing (NGS)
  • Polymerase Chain Reaction (PCR)

Answer: Next-generation sequencing (NGS)

9. The field of “pharmacogenomics” was able to advance rapidly after the HGP because the project provided:

  • A comprehensive reference map of the human genome, making it possible to identify genetic variations that influence drug response.
  • The first antibiotic.
  • A cure for cancer.
  • A new class of antidepressant medications.

Answer: A comprehensive reference map of the human genome, making it possible to identify genetic variations that influence drug response.

10. The discovery of numerous “single nucleotide polymorphisms” (SNPs) by the HGP is fundamental to understanding:

  • The differences in disease susceptibility and drug response among individuals.
  • The process of DNA replication.
  • The structure of the ribosome.
  • The mechanism of action of all drugs.

Answer: The differences in disease susceptibility and drug response among individuals.

11. The “forging ahead” mindset in pharmacy means using the knowledge gained from the HGP to:

  • Move towards a more personalized and precise approach to medicine.
  • Maintain a traditional, one-size-fits-all approach to prescribing.
  • Focus only on dispensing.
  • Resist the use of genetic testing in clinical practice.

Answer: Move towards a more personalized and precise approach to medicine.

12. A “business plan” for a new pharmacogenomics testing company would cite the HGP as:

  • An irrelevant historical event.
  • The foundational scientific achievement that made its business model possible.
  • A major competitor.
  • A regulatory barrier.

Answer: The foundational scientific achievement that made its business model possible.

13. A pharmacist’s “leadership” is shown when they advocate for the clinical implementation of:

  • Outdated medical practices.
  • Evidence-based genomic medicine, which is a direct legacy of the HGP.
  • The use of fewer technologies in healthcare.
  • A reduction in patient counseling.

Answer: Evidence-based genomic medicine, which is a direct legacy of the HGP.

14. The “regulation” of new genetic tests and gene therapies that resulted from the HGP is the responsibility of the:

  • DEA
  • FDA
  • CMS
  • EPA

Answer: The FDA

15. A key “policy” debate that arose from the HGP and is still relevant today is:

  • How to ensure the privacy of an individual’s genetic information.
  • Whether pharmacists should be allowed to give immunizations.
  • The appropriate price for over-the-counter medications.
  • The schedule for controlled substances.

Answer: How to ensure the privacy of an individual’s genetic information.

16. The “financials” of the HGP involved a significant public investment. The return on that investment is seen in:

  • The growth of the biotechnology industry.
  • The development of new diagnostics and therapies.
  • Improved public health.
  • All of the above.

Answer: All of the above.

17. The “service” of providing MTM for complex patients is enhanced by the legacy of the HGP through the field of:

  • Pharmacogenomics, which can explain why a patient is having a side effect or not responding to a drug.
  • Marketing.
  • Health economics.
  • Pharmacy law.

Answer: Pharmacogenomics, which can explain why a patient is having a side effect or not responding to a drug.

18. A pharmacist’s knowledge of “human resources” in a modern research hospital would include understanding the need to recruit personnel with expertise in:

  • Bioinformatics and genomics, fields that exploded after the HGP.
  • Only traditional chemistry.
  • Marketing.
  • Finance.

Answer: Bioinformatics and genomics, fields that exploded after the HGP.

19. A key part of the “Introduction to Pharmacy Informatics” is understanding that the HGP created a massive amount of data that required the development of new ways to:

  • Store, analyze, and retrieve biological information.
  • Chart on paper.
  • Communicate via fax machine.
  • Manage pharmacy inventory.

Answer: Store, analyze, and retrieve biological information.

20. An “Electronic Health Record” (EHR) of the future will need to integrate a patient’s __________ into the clinical record, a direct result of the HGP’s success.

  • Social media profile.
  • Genomic data.
  • Financial history.
  • Favorite color.

Answer: Genomic data.

21. “Clinical Decision Support” systems can use the genomic information made available by the HGP to:

  • Alert a provider if they are prescribing a drug that is known to be ineffective or harmful based on a patient’s genetic makeup.
  • Order a patient’s lunch.
  • Schedule a follow-up appointment.
  • Bill for a hospital stay.

Answer: Alert a provider if they are prescribing a drug that is known to be ineffective or harmful based on a patient’s genetic makeup.

22. An “analytics and reporting system” can use population-level genomic data, a legacy of the HGP, to:

  • Identify new drug targets and disease-associated genes.
  • Track pharmacy profits.
  • Manage technician schedules.
  • Analyze customer satisfaction.

Answer: Identify new drug targets and disease-associated genes.

23. The “human factors” of displaying complex genomic information from the HGP in an EHR is a major challenge that requires:

  • Presenting the raw DNA sequence to the clinician.
  • Designing interfaces that provide clear, concise, and actionable recommendations.
  • Using a very small font size.
  • Hiding the information from the provider.

Answer: Designing interfaces that provide clear, concise, and actionable recommendations.

24. “Artificial intelligence” and “machine learning” are now being used to analyze the vast datasets that originated from the HGP in order to:

  • Predict disease risk and identify novel biological pathways.
  • Replace all human clinicians.
  • Make healthcare more expensive.
  • Write prescriptions.

Answer: Predict disease risk and identify novel biological pathways.

25. A “negotiation” with a payer for a new, expensive targeted therapy that is based on a genetic marker would use the scientific foundation of the HGP to:

  • Justify the drug’s mechanism and its benefit in a specific, genetically-defined population.
  • Argue that the price is too high.
  • Discuss the history of the HGP.
  • Focus only on the patient’s preference.

Answer: Justify the drug’s mechanism and its benefit in a specific, genetically-defined population.

26. The “DNA structure” was elucidated by Watson and Crick, but the HGP provided the complete ________ of that structure for humans.

  • Physical model
  • Nucleotide sequence
  • Chemical formula
  • Historical context

Answer: Nucleotide sequence

27. The HGP’s mapping of genes allows for a better understanding of the function of “enzymes of DNA metabolism” by:

  • Identifying the genes that code for these enzymes and where they are located.
  • Changing how the enzymes work.
  • Proving these enzymes do not exist.
  • It is not related.

Answer: Identifying the genes that code for these enzymes and where they are located.

28. The “molecular biology technique” of “cloning” was essential for the HGP to:

  • Create a human being.
  • Make many copies of DNA fragments to be sequenced using the Sanger method.
  • Separate proteins by size.
  • Analyze a patient’s blood type.

Answer: Make many copies of DNA fragments to be sequenced using the Sanger method.

29. The “basic principles of inheritance” described by Mendel were explained at a molecular level by the findings of the HGP, which linked traits to:

  • The environment only.
  • Specific genes at specific locations on chromosomes.
  • The blood type of the parents.
  • The number of chromosomes.

Answer: Specific genes at specific locations on chromosomes.

30. The “oncogene” and “tumor suppressor” genes that drive cancer were definitively identified and mapped through the HGP, which has revolutionized:

  • Cancer diagnostics and the development of targeted therapies.
  • The treatment of infectious diseases.
  • The management of cardiovascular disease.
  • The practice of community pharmacy.

Answer: Cancer diagnostics and the development of targeted therapies.

31. The “Human Proteome Project,” which aims to map all human proteins, is a logical next step that was made possible by:

  • The HGP providing the “parts list” of genes that code for those proteins.
  • The discovery of the first antibiotic.
  • The invention of the microscope.
  • The development of sterile compounding techniques.

Answer: The HGP providing the “parts list” of genes that code for those proteins.

32. The Genetic Information Nondiscrimination Act (GINA) is a direct policy outcome of the ________ program of the HGP.

  • Financial
  • ELSI
  • Technical
  • Sequencing

Answer: ELSI

33. The HGP was an international collaboration. Which country was the primary partner with the United States?

  • Germany
  • Japan
  • The United Kingdom
  • All of the above were significant partners.

Answer: All of the above were significant partners.

34. The “public vs. private” race to sequence the genome involved the publicly funded HGP and which private company led by Craig Venter?

  • Genentech
  • Amgen
  • Celera Genomics
  • Pfizer

Answer: Celera Genomics

35. A “health disparity” could be worsened by the legacy of the HGP if:

  • The benefits of genomic medicine are not accessible to all populations equitably.
  • All populations are included in genomic research.
  • The cost of genetic testing becomes very low.
  • All pharmacists are trained in pharmacogenomics.

Answer: The benefits of genomic medicine are not accessible to all populations equitably.

36. A pharmacist’s role in “drug use and prevention” is impacted by the HGP, as research into the ________ of addiction is a major field of study.

  • Social causes
  • Environmental causes
  • Genetics
  • Psychology

Answer: Genetics

37. The “advocacy” role of a pharmacist in the genomic era includes:

  • Advocating for rational, evidence-based use of genetic testing in clinical practice.
  • Promoting the use of all available genetic tests for all patients.
  • Resisting the use of any genetic information in patient care.
  • Focusing only on the cost of testing.

Answer: Advocating for rational, evidence-based use of genetic testing in clinical practice.

38. The “Introduction to the Profession” course for a modern pharmacist must include the HGP because:

  • It fundamentally changed the scientific basis of medicine and pharmacy.
  • It is a minor historical footnote.
  • It is only relevant to researchers.
  • It is required for state licensure.

Answer: It fundamentally changed the scientific basis of medicine and pharmacy.

39. The “bioethics” discussions that were a key part of the HGP have shaped the principles of:

  • Informed consent for genetic testing.
  • Data privacy and security.
  • The return of incidental findings.
  • All of the above.

Answer: All of the above.

40. The HGP has allowed for a much deeper understanding of “eukaryotic and prokaryotic transcription” by:

  • Identifying the complete set of transcription factor genes and the regulatory sequences they bind to.
  • Proving that prokaryotes do not have transcription.
  • It did not contribute to this field.
  • Showing that all genes are transcribed at all times.

Answer: Identifying the complete set of transcription factor genes and the regulatory sequences they bind to.

41. The findings of the HGP are critical for understanding “epigenetics” because:

  • They provide the underlying DNA sequence upon which epigenetic marks are placed and interpreted.
  • Epigenetics is not related to the DNA sequence.
  • The HGP sequenced the epigenome.
  • The two fields are in conflict with each other.

Answer: They provide the underlying DNA sequence upon which epigenetic marks are placed and interpreted.

42. A “health disparity among people with disabilities” could be addressed by the HGP’s legacy through:

  • The identification of genes that cause certain disabilities, leading to new therapies.
  • The development of more inclusive clinical trials.
  • The creation of assistive technologies.
  • All of the above.

Answer: All of the above.

43. The “services” a pharmacist can offer in the post-HGP era include:

  • Pharmacogenomic consulting.
  • Counseling on direct-to-consumer genetic tests.
  • MTM that incorporates genetic data.
  • All of the above.

Answer: All of the above.

44. The “human factors” of using genomic data in the EHR is a major challenge. A key principle is to:

  • Display the entire 3 billion base pairs of a patient’s genome to the provider.
  • Design systems that deliver only the relevant, actionable genomic information at the point of care.
  • Use a command-line interface for all genomic data.
  • Keep the genomic data in a separate, inaccessible system.

Answer: Design systems that deliver only the relevant, actionable genomic information at the point of care.

45. A “leader” in pharmacy today must have a foundational understanding of the HGP to:

  • Guide their organization into the future of personalized medicine.
  • Focus only on the traditional dispensing model.
  • Ignore the impact of genetics on healthcare.
  • Make decisions based on intuition alone.

Answer: Guide their organization into the future of personalized medicine.

46. How did the HGP contribute to our understanding of “RNA tumor viruses”?

  • By sequencing the human genome, it became easier to identify the integration sites of proviruses and the proto-oncogenes they affect.
  • It cured all diseases caused by RNA tumor viruses.
  • It proved that RNA tumor viruses do not exist.
  • It had no impact on this field.

Answer: By sequencing the human genome, it became easier to identify the integration sites of proviruses and the proto-oncogenes they affect.

47. The “molecular biology technique” of “next-generation sequencing” was a direct technological successor to the methods used in the HGP, allowing for:

  • Much faster and cheaper sequencing of entire genomes.
  • The separation of proteins.
  • The amplification of a single gene.
  • The cloning of an organism.

Answer: Much faster and cheaper sequencing of entire genomes.

48. The “basic principles of inheritance” are now understood at the molecular level thanks to the HGP, which allows a trait to be traced to:

  • A specific gene with a known sequence and chromosomal location.
  • A blend of parental fluids.
  • A miasma or bad air.
  • The four humors of the body.

Answer: A specific gene with a known sequence and chromosomal location.

49. The HGP’s complete mapping of DNA repair genes is critical for understanding:

  • The genetic basis of hereditary cancer syndromes like Lynch syndrome.
  • How cells protect themselves from mutations.
  • The mechanisms of resistance to certain chemotherapy drugs.
  • All of the above.

Answer: All of the above.

50. The ultimate and most enduring legacy of the Human Genome Project is that it:

  • Provided a single “book of life” that answered all questions about human biology.
  • Marked the end of biological research.
  • Provided a foundational resource and a set of tools that continues to drive discovery in medicine and pharmacy today.
  • Was a project with no lasting impact.

Answer: Provided a foundational resource and a set of tools that continues to drive discovery in medicine and pharmacy today.

Leave a Comment